Therefore, the KCa3.1 channel may serve as a potential therapeutic target for diseases associated with cell activation and hyperproliferation, such as diabetic nephropathy (6), ulcerative colitis (7), and RA (8). Here, KCNN4 is linked to rheumatoid arthritis.